INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016
open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15
The pharmaceutical sector is distinguished by a complicated interaction between branded and generic medications. Branded pharmaceuticals manufactured and marketed by pharmaceutical corporations sometimes have exclusivity periods due to patents, allowing them to fetch higher costs. When patents expire, generic rivals join the market and offer comparable drugs at reduced prices. This dynamic fosters fierce rivalry, affecting pricing tactics, market share, and innovation. This research investigates the dynamics of competition between branded and generic medications. It investigates the variables that influence generic market entrance, such as legislative channels and litigation, as well as pharmaceutical corporations' strategy for maintaining market dominance. It also analyses how healthcare policy and regulations shape this competitive landscape. Furthermore, the research explores how branded-generic rivalry affects healthcare accessibility, pricing, and patient welfare. It emphasizes the importance of generic medicine availability in lowering healthcare costs and boosting pharmaceutical accessibility, particularly in poor nations. However, it notes concerns about the quality and safety of generic pharmaceuticals, as well as the possible influence on innovation incentives in the pharmaceutical business. Overall, this article sheds light on the intricacies of branded-generic medication rivalry and its ramifications for stakeholders throughout the healthcare ecosystem, including patients, providers, governments, and pharmaceutical corporations. It emphasizes the significance of combining innovation incentives with the requirement for inexpensive and accessible pharmaceuticals in order to achieve optimal healthcare outcomes for all.
Keywords:
Branded generic drug, pharmaceutical industry, drug competition.
Cite Article:
"Branded Generic Drugs and Competition", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.9, Issue 4, page no.1408 - 1416, April-2024, Available :http://www.ijsdr.org/papers/IJSDR2404206.pdf
Downloads:
000338176
Publication Details:
Published Paper ID: IJSDR2404206
Registration ID:211119
Published In: Volume 9 Issue 4, April-2024
DOI (Digital Object Identifier):
Page No: 1408 - 1416
Publisher: IJSDR | www.ijsdr.org
ISSN Number: 2455-2631
Facebook Twitter Instagram LinkedIn